Table 1 Clinical and electrophysiological characteristics at day 0.
| Disease course | RR‐MS | SP‐MS | PP‐MS | ION | ||||
|---|---|---|---|---|---|---|---|---|
| Number of patients | 24 | 8 | 9 | 4 | ||||
| Sex (female:male) | 11:13 | 5:3 | 5:4 | 1:3 | ||||
| Age (years) | 36 (23 to 54) | 48 (32 to 59) | 54 (32 to 59)* | 46 (43 to 50) | ||||
| Disease duration (months) | 8.5 (0.3 to 240) | 74 (15 to 384) | 12 (12 to 84)* | to | ||||
| Duration of relapse (months) | 1 (0.3 to 7) | 2.4 (0.3 to 4.5) | 4 (0.3 to 7) | 0.8 (0.3 to 1) | ||||
| EDSS | 3 (1.5 to 4) | 4 (2.5 to 6) | 3 (2 to 6.5)* | to | ||||
| Paresis (MRC grade) | 5 (3 to 5) | 4 (3 to 5) | 4 (3 to 5) | 5 (5 to 5) | ||||
| TST amplitude ratio (%) | 68.8 (7.8 to 98.6) | 33.5 (15.9 to 84.4) | 52.6 (3.6 to 86.7) | 95.5 (91.9 to 100) | ||||
| CMCT (ms) | 15.6 (7.2 to 30.4) | 20.8 (17.6 to 28.1) | 21.8 (16.5 to 32.8)* | 12.5 (11.2 to 14.5) |
Values are median (range) or n.
*p<0.01 for comparison of multiple sclerosis patients (Kruskal–Wallis test).
CMCT, central motor conduction time; EDSS, extended disability scale score; ION, isolated optic neuritis; MRC, Medical Research Council; PP‐MS, primary progressive multiple sclerosis; RR‐MS, relapsing‐remitting multiple sclerosis; SP‐MS, secondary progressive multiple sclerosis; TST, triple stimulation technique.